F G FR during this process is the ras/MAPK pathway (Schlessinger, 2000) . Inhibition of any component of and Enrique Amaya 1,2, * this pathway subsequently blocks the expression of 1 The Wellcome Trust/Cancer Research UK Gurdon mesodermal markers (Gupta and Mayer, 1998; MacInstitute Nicol et al., 1993; Tang et al., 1995; Whitman and MelUniversity of Cambridge ton, 1992) . F G F signaling has also been shown to diTennis Court Road Cambridge rectly affect morphogenetic cell movements during C B2 1QN gastrulation (Ciruna et al., 1997; Yang et al., 2002) . We United Kingdom have shown that this effect occurs through the F G FR 2 Department of Zoology via a mechanism that is distinct from the ras/MAPK University of Cambridge pathway (Nutt et al., 2001) . Therefore, F G FR signaling Downing Site, Cambridge is used both for maintaining mesoderm fate and for regUnited Kingdom ulating morphogenesis. However, how does the embryo interpret the signals correctly so that mesoderm maintenance and morphogenesis occur in a coordinated Summary fashion?
We have previously reported that the receptor tyroVertebrate gastrulation requires coordination of mesosine kinase (RTK) inhibitor protein, Xsprouty2, inhibits derm specification with morphogenetic movements.
F G FR-mediated morphogenesis but leaves mesoderm While both of these processes require FGF signaling, formation intact (Nutt et al., 2001 ). The Sprouty family it is not known how mesoderm specification and cell was first discovered from a Drosophila mutation that movements are coordinated during gastrulation. The mimicked the effects of overactive F G F signaling (Harelated Sprouty and Spred protein families are recently cohen et al., 1998) . A family of conserved Sprouty discovered regulators of receptor tyrosine kinase siggenes have since been identified that act as intracellunaling. We identified two genes for each family in Xenolar inhibitors of RTK signaling, with homologs found in pus tropicalis: Xtsprouty1, Xtsprouty2, Xtspred1, and mice, humans, zebrafish, and Xenopus (Christofori, Xtspred2. In gain-and loss-of-function experiments we Guy et al., 2003) . Sprouty family members share show that XtSprouty and XtSpred proteins modulate a conserved cysteine-rich carboxy-terminal domain different signaling pathways downstream of the FGF (Spry) and divergent amino termini (Guy et al., 2003) .
receptor (FGFR), and consequently different develop-
Recently, a Sprouty-related family, the Spreds, has also mental processes. Notably, XtSproutys inhibit morbeen described; they have been shown to inhibit RTK phogenesis and Ca 2+ and PKC␦ signaling, leaving MAPK signaling as well. Spreds share the Spry domain but activation and mesoderm specification intact. In concontain an N-terminal Enabled/VASP homology 1 dotrast, XtSpreds inhibit MAPK activation and mesomain (EVH1), and most have a binding sequence for derm specification, with little effect on Ca 2+ or PKC␦ the oncogenic RTK c-kit (Kato et al., 2003; Wakioka et signaling. These differences, combined with the timing al.
, 2001). of their developmental expression, suggest a mecha-
The biological roles of Sprouty and Spred proteins nism to switch FGFR signal interpretation to coordiremain unclear due to results suggesting they have a nate mesoderm formation and cell movements durvariety of effects on RTK signaling. The majority of ating gastrulation.
tention has focused on inhibition of MAPK activation by Sprouty proteins downstream of RTK signaling Introduction (Casci et al., 1999; Hanafusa et al., 2002) . However, Sprouty family members have been shown to have variThe formation and patterning of mesoderm represents able effects on MAPK activation and even enhance a critical stage of vertebrate development. During gas-MAPK signaling Wong et al., 2002 ; trulation, mesodermal tissue must be coordinately in- Yusoff et al., 2002) . We have shown that Xsprouty2 efduced and directed through a series of morphogenetic fectively inhibits Ca 2+ signaling but has little effect on movements inside the embryo to form derivatives, such MAPK activation in vivo (Nutt et al., 2001 , 2001) . Notably, mammalian Spreds have been obfactors, including members of the fibroblast growth served to be more potent inhibitors of MAPK activity factor family (F G Fs) (Sivak and Amaya, 2004) .
than Sproutys in vitro ). We have shown previously that disrupting F G F reHere we have identified two members of each the ceptor (F G FR) signaling inhibits mesoderm induction Sprouty and Spred families in the diploid frog Xenopus and maintenance (Amaya et al., 1991; Kroll and Amaya, tropicalis: Xtsprouty1 and Xtsprouty2 and Xtspred1 and 1996) . The prominent pathway downstream of the Xtspred2. Using both gain-and loss-of-function experiments, we show that these two families of proteins help modulate F G F signal interpretation in the early embryo by inhibiting distinct downstream signal transduction Figure 1 . Morphogenesis Requires F G FR Signaling Independent of MAPK (A) Western blots against embryo lysates from various stages probed for active MAPK (dp-MAPK) and pan-MAPK. MAPK activity peaked at stage 11 and decreased by stage 14, and then returned at stage 19.
(B) Blots for dp-MAPK and pan-MAPK against DMZ lysates at corresponding stages. Again, MAPK activity peaked at stage 11 and decreased sharply at stage 12, remaining low until stage 18. (C) DMZ extension (m) plotted against the corresponding stage. The majority of extension occurred between stages 12-16. Error bars represent standard deviation.
(D) dp-MAPK blots from animal cap lysates incubated for 15 min with and without F G F2 in the presence of increasing concentrations of F G FR1 inhibitor (SU5402) or MEK1 inhibitor (U0126). Both drugs abolished F G F-induced MAPK activation in a dosage-dependent manner.
(E) Embryos injected with 10 nl of 2 mM SU5402, U0126, or DMSO into the blastocell and cultured with the same inhibitor at stage 8 or 12.5. Stage 8 treated embryos were fixed at stage 11.5 and 29-30 for in situ hybridization for Xbra and cardiac actin, respectively. Both inhibitors blocked mesoderm specification and gastrulation movements when treated at stage 8. Embryos treated at stage 12.5 with SU5402 exhibited morphogenetic defects, but U0126-treated were unaffected.
pathways and thereby help coordinate mesoderm MAPK was active in the tissues undergoing active morphogenesis, we assayed MAPK activity in dissected specification and morphogenesis.
dorsal marginal zone (DMZ) explants. Consistent with results from whole embryos, MAPK activity peaked in Results stage 11 DMZs and decreased by stage 12, where it remained low until stage 18 ( Figure 1B) . Notably, during FGFR Signaling Is Required for Morphogenesis the stages when MAPK activity was low we found that but Is Not Dependent on MAPK Activity the DMZs were most actively undergoing morphogeneWe have previously shown that Xsprouty2 inhibits F G Fsis ( Figure 1C ), suggesting that MAPK signaling is not dependent morphogenesis but does not affect mesorequired for this process. derm specification or MAPK activity in vivo. However, To determine whether F G FR signaling is necessary the role of MAPK signaling during morphogenesis has for morphogenesis independently of MAPK, we used remained unclear. We therefore conducted a series of chemical inhibitors of the F G F receptor (SU5402) and experiments to directly test the requirements of MAPK MEK1 (U01236) to disrupt all F G FR activity or just activation for morphogenetic movements during meso-MAPK activation, respectively. Both SU5402 and U0126 derm formation.
successfully inhibited F G F-stimulated MAPK activation First we determined the temporal profile of activated in animal caps in a dose-dependent manner ( Figure  MAPK during the stages when morphogenetic move-1D). Embryos were then treated with SU5402, U0126, ments are active during development, using antibodies or DMSO control at stage 8 (before mesoderm specifispecific for activated MAPK (dp-MAPK). We found that cation) and stage 12.5 (after mesoderm specification, MAPK was active at stage 11 during mesoderm specifibut prior to the stages of most extensive morphogenecation, but activity decreased by stage 14, after mesoderm had formed, and remained low until the late neusis). Embryos exposed to either SU5402 or U0126 at stage 8 failed to complete gastrulation, resulting in an rula stages ( Figure 1A) . In order to determine whether open blastopore phenotype with decreased expression weak or absent in the midbrain/hindbrain isthmus and forebrain and did not extend as far posteriorly in the of mesodermal markers Xbrachyury (Xbra) and cardiac actin ( Figure 1E) and Xtspred genes are expressed at the same relative times. Since in situ hybridization data are not quantitaconsistent with the effects of disrupting the F G FR or ras/MAPK pathway during early stages of developtive, we decided to answer this question using quantitative real-time RT-PCR. We found that, although the ment. In comparison, embryos treated with the F G FR inhibitor (SU5402) at stage 12.5 showed morphogenetic Xtsprouty and Xtspred genes share similar spatial patterns, they have important temporal differences. The defects resulting in a shortened anterior-posterior (A-P) axis, whereas embryos treated with the MAPK inhibitor relative expression levels by real-time RT-PCR of Xtspry1 and Xtspry2 was higher during early gastrula (U0126) developed normally ( Figure 1E) Embryos injected with Xtsproutys developed a shortBased on our previous work, we hypothesized that ened A-P axis, compared to controls injected with a Sprouty family members may be involved in regulating nonfunctional F G F receptor (HAV\) or uninjected em-F G FR signal interpretation during development. We bryos ( Figures 3A and 3B ). Interestingly, this phenotype isolated two X. tropicalis sprouty genes, Xtsprouty1 is similar to that caused by treatment with an F G FR (Xtspry1) and Xtsprouty2 (Xtspry2), and two related spred inhibitor at stage 12.5 ( Figure 1E ). In comparison, emgenes, Xtspred1 (Xtsprd1) and Xtspred2 (Xtsprd2). As bryos injected with Xtspreds developed an open blaswith their mammalian counterparts, all the identified topore phenotype reminiscent of the effects of early XtSprouty and XtSpred proteins share a conserved cys-F G FR inhibition ( Figure 1E ). These results prompted teine-rich C-terminal Spry domain. The two Sprouty further investigations to determine if the differences beproteins contain an uncharacterized N-terminal domain tween the Xtsproutys and Xtspreds were variations in whose function remains obscure (Guy et al., 2003) , severity of the same phenotype or caused by distinct while the two Spreds contain an N-terminal EVH1 dounderlying molecular mechanisms. main and c-Kit binding domain (KBD) (Harmer et al., 2005; Wakioka et al., 2001 ) ( Figure 2A ). All proteins contain a high degree of identity to their human counterXtSpreds Inhibit Mesoderm Specification but XtSproutys Do Not parts: 72.9% for Sprouty1, 72.7% for Sprouty2, 60.1% for Spred1, and 69.9% for Spred2.
Early disruption of F G FR function blocks specification of mesoderm as well as failure to complete gastrulaThe Xtsprouty and Xtspred genes are all expressed in broadly similar patterns to X. laevis sprouty2 and a tion. This effect is due to interruption of the MAPK signaling cascade controlling transcriptional activation of number of F G Fs, including XF G F8, XeF G F, and F G F-9 (Christen and Slack, 1997; Isaacs et al., 1994; Nutt et al., mesodermal genes, such as the T-box transcription factor Xbrachyury (Xbra) (Sivak and Amaya, 2004) . We 2001; Song and Slack, 1996) . During gastrula stages, expression was first localized to the dorsal marginal zone, tested the effects of Xtsprouty and Xtspred overexpression on mesoderm specification and MAPK activity. A but later expanded laterally and ventrally. Although all four genes displayed this pattern, Xtspry1 and Xtspry2 series of in situ hybridizations was carried out for Xbra on mid-gastrula embryos that had been coinjected with were detected earlier and expanded their expression pattern more quickly than Xtsprd1 and Xtsprd2 ( Figure  either Xtsprouty or Xtspred, and β-gal RNAs into one blastomere at the two-cell stage. Control-injected em-2B). During neurula stages, expression became confined anteriorly and posteriorly and expanded to varybryos showed a characteristic ring of Xbra expression in the marginal zone around the blastopore. Injections ing degrees along the neural tube. Generally, staining for Xtsproutys became weaker and more localized, of either Xtsprouty had little effect on Xbra; however, both Xtspreds completely blocked Xbra expression on while Xtspreds became stronger and more broad. At tail bud stages, staining became localized to the dethe injected side ( Figure 3C ). We then assayed the effects of XtSprouty and veloping branchial arches, forebrain, otic vesicle, midbrain/hindbrain isthmus, and tail bud. Xtspry2 staining XtSpred proteins on MAPK activity, using the dp-MAPK antibody. As shown previously, during gastrulation was absent from the third branchial arch; however, this feature was stained for Xtspry1, Xtsprd1, and Xtsprd2 there is a sharp F G F-dependent increase in the amount of activated MAPK, concomitant with mesoderm specimRNAs. Comparatively, Xtspred gene expression overlapped considerably with the Xtsprouty genes, with the fication ( Figure 1A) . When 1.0 ng RNAs was injected into both blastomeres, neither XtSprouty had an effect exception that staining for the Xtspred genes was either In situ hybridizations for each gene. At gastrula stages (stage 10.5), Xtsproutys showed more extensive staining around the blastopore than Xtspreds (arrow). Neurula stages showed increased staining of Xtspreds and decreased Xtsproutys. Tail bud stages showed similar staining in branchial arches (br), otic vesicle (ov), and tail bud (tb), but Xtspred staining was absent in mid-brain/hind-brain isthmus (mhb) and forebrain (fb). (C) Quantitative real-time RT-PCR analysis of each gene's expression over time. Relative expression levels showed Xtsproutys peak before stage 12.5 and then diminish, while Xtspreds levels increased after stage 12.5. on MAPK activity. However, both XtSpred proteins This suggests that the XtSpred proteins are much more effective inhibitors of MAPK signaling than the XtSprouty blocked MAPK signaling as efficiently as the dominantnegative F G F receptor (XFD) ( Figure 3D ). Since Sprouty proteins in vivo. Others have similarly reported that mammalian Spred proteins are more effective MAPK inproteins have been studied as inhibitors of the MAPK signaling pathway in vitro, we tested the possibility that hibitors than the Sprouty proteins . the XtSproutys might be more effective at inhibiting MAPK activation at higher concentrations. A dosage
We also tested the effect of F G F-induced MAPK activation in animal caps. Compared to the results in Figure  series with the most effective family member, Xtspry2, was able to slightly reduce MAPK activation at the 3D, which tested steady state MAPK activity in whole embryos, this experiment directly tested the F G Fhighest amount tested (2 ng), but Xtsprd1 completely abolished MAPK activation even at 1 ng ( Figure 3E) . dependent activation of MAPK in animal caps after 15 (C) Embryos coinjected with RNAs and β-gal into one blastomere at the two-cell stage. X-gal staining (blue, arrows) and in situ hybridization for Xbra (purple) at the mid-gastrula (stage 11) showed that both Xtsprd1 and Xtsprd2 blocked Xbra expression but Xtspry1 and Xtspry2 had little effect.
(D) Western blots of lysates from stage 11 embryos injected into both blastomeres and probed for dp-MAPK or pan-MAPK. HAV\ control showed a dp-MAPK band that was blocked by XtSprd1, XtSprd2, and dnF G FR (XFD). XtSpry1 and XtSpry2 had no effect on MAPK activation.
(E) Dosage series of lysates from stage 11 embryos injected as above with 0.25, 1.0, and 2.0 ng RNAs. XtSprd1 was much more effective than XtSpry2 at reducing dp-MAPK signal.
(F) Blot of animal cap lysates cultured with and without F G F2 for 15 min and then probed for dp-MAPK. HAV\ control showed an increase of dp-MAPK when F G F2 treated. This signal was absent from caps injected with Xtsprd1 and XFD, but not from caps injected with Xtspry2. UI, uninjected embryo; HAV\, control RNA; XFD, dominant-negative F G FR.
min. As expected, untreated caps did not contain actiactivin treatment, control caps express mesodermal vated MAPK. Addition of F G F2 to control-injected caps markers and undergo F G F-dependent convergent exled to a clear increase in activated MAPK, which was tension movements (Cornell and Kimelman, 1994) . In blocked by injection of dnF G FR (XFD). MAPK activation this experiment the most effective members of each was largely unaffected by injection of 1.0 ng Xtspry2 family, Xtspry2 and Xtsprd1, were injected into animal RNA but was blocked by Xtsprd1 ( Figure 3F) .
poles. Each resulted in inhibition of cap extension in the presence of activin ( Figure 4A ). In light of the phenotypic differences we had observed, we wondered XtSproutys Inhibit Morphogenesis Independently whether the inhibition of cap extension was due to the of Mesoderm Specification same underlying factors. RT-PCR was performed on We tested the effects of the Xtsproutys and Xtspreds gastrula (stage 11) caps injected as above with primers on morphogenesis using an animal cap assay. Animal amplifying the mesodermal marker Xbra ( Figure 4B ). As caps were dissected from injected embryos and cultured in the presence or absence of activin. Under expected, HAV\ control caps showed little Xbra expres- increased Xbra expression in untreated caps, but had no effect after activin treatment. Xtsprd1 inhibited Xbra expression with activin.
(C) Oocyte assay of Ca 2+ signaling. Release of 45 Ca 2+ from oocytes coinjected with constitutively active F G FR (CIXR) and the indicated RNAs was counted after 10 min. Addition of CIXR increased 45 Ca 2+ release 5-fold (HAV\). Coexpression of dominant-negative CIXR (CIXD), Xtspry1, Xtspry2, or X. laevis Sprouty2 (Xspry2) effectively blocked this increase. Xtsprd1 had significantly less effect, and Xtsprd2 and Xtsef had no effect. Error bars represent standard deviation. (D) Confocal images of PKCδ-G FP expressed in animal caps and cultured for 10 min in the presence of either 1 M PMA, 100 ng/ml F G F2, or coexpressed XtSpry2 or XtSprd1 as indicated. PKCδ was activated by both PMA and F G F2 and localized to the membrane. XtSpry2 inhibited F G F-induced localization of PKCδ but XtSprd1 did not. sion unless treated with activin to induce mesoderm.
in the absence of activin. In comparison, injection of Xtsprd1 inhibited the induction of Xbra after activin Xtspry2 had no effect on Xbra induction with activin, and surprisingly caused an increase in Xbra expression treatment. et al., 2004) . MO sequences were depathways that can be induced following F G FR activasigned to specifically target splice junctions for each tion. Another prominent downstream pathway acts Xtsprouty and Xtspred pre-mRNA. A cartoon depicting through phospholipase Cγ (PLCγ). PLCγ hydrolyzes the design and targeting of splice morpholinos is phosphatidylinositol into diacylglycerol (DAG) and inoshown in Figure 5A . Each MO sequence was desigsitol trisphosphate (IP 3 ), which activates the IP 3 recepnated by its target location (e.g., e1i1 for the exon1-tor in the endoplasmic reticulum, causing an efflux of intron1 boundary, i1e2 for the intron1-exon2 boundary, Ca 2+ into the cytoplasm (Schlessinger, 2000) . Localized etc.). We confirmed the effectiveness of the morphoCa 2+ signaling has been linked to convergent extension linos by assaying for splicing interference by performmovements during Xenopus gastrulation (Wallingford et ing RT-PCR using primers across each splice junction. al., 2001). We have previously reported that X. laevis Affected transcripts either amplified at different sizes Sprouty2 inhibits F G F-induced Ca 2+ mobilization in an or failed to amplify ( Figure 5B ). efflux assay using Xenopus oocytes (Nutt et al., 2001) .
X. tropicalis embryos were used for these experiUsing the same assay we compared the effect of the ments as their diploid genome allows for much simpler XtSprouty and XtSpred proteins on F G FR-induced Ca 2+ loss-of-function interpretation than the allotetraploid X. release. Both XtSpry1 and XtSpry2 were as effective as laevis. In each experiment, MOs were injected into zy-X. laevis Spry2 in blocking Ca 2+ release ( Figure 4C ). In gotes before first cleavage. As a control, a MO containcontrast, XtSprd1 only partially inhibited Ca 2+ release ing four mismatches to the Xtspry2 sequence (4-mis) and XtSprd2 was ineffective. A negative control was was used. Injection of MOs targeted to the Xtsprouty provided by XtSef, an inhibitor of F G FR signaling that and Xtspred genes developed markedly different phetargets the Ras/MAPK pathway and bears no homology notypes ( Figures 5C and 5E ). In these experiments, to the Sprouty family (Furthauer et al., 2002) . These recombinations of splice MOs were used in order to results provide additional evidence that XtSprouty and duce the effects of functional redundancy between XtSpred proteins target different signaling pathways family members. A combination of Xtspry1 and Xtspry2 downstream of F G FR activation.
MOs (Spry1 i1e2 and Spry2 e1i1) caused anterior-posterior truncations. These results were similar to the FGF-Induced PKC␦ Localization Is Inhibited gain-of-function effect ( Figure 3A) , which might be exby XtSproutys but Not by XtSpreds pected if coordination of morphogenesis was disAnother important secondary messenger produced by rupted. In contrast, MOs targeting the Xtspred genes PLCγ in addition to IP 3 is DAG. The most prominent (using a combination of Sprd1 e1i1 and Sprd2 e2i2 intracellular targets of DAG belong to the protein kinase MOs) produced a more severe phenotype, with em-C (PKC) family. Kinoshita et al. (2003) recently demonbryos appearing ventro-posteriorized (Figures 5C and strated that upon activation, PKCδ, a member of the 5E). This effect is reminiscent of that reported for emnovel (nPKC) subfamily, translocates to the cell membryos with overactive F G FR signaling (Isaacs et al., brane where it is an essential component of the nonca-1994). Xtsprd MO-injected embryos had diffuse and nonical Wnt, or planar cell polarity, signaling pathway.
weak cardiac actin staining and had either absent or Inhibition of PKCδ disrupts convergent extension moveundifferentiated notochords ( Figures 5C and 5D ). Simiments during gastrulation, but does not block the expreslarly, Xtsprd MO embryos showed no staining for the sion of mesodermal markers (Kinoshita et al., 2003) .
notochord marker FK506 binding protein (Spokony and Given the similarities of these results to our observaSaint-Jeannet, 2000) ( Figures 5E and 5F ). In contrast, tions with XtSproutys, and that nPKC proteins rely Xtspry MO-injected embryos stained normally for solely on DAG for activation (Gschwendt, 1999), we cardiac actin expression and the notochord was clearly tested whether F G FR signaling can activate PKCδ.
visible ( Figures 5C-5F ). Membrane localization of G FP-tagged PKCδ was observed in animal caps using confocal microscopy (Figure 4D) . PKCδ-G FP signal was diffuse in untreated XtSprouty Depletion Causes Animal Caps to Undergo Morphogenetic Extension, while caps, but addition of phorbol 12-myristate 13-acetate (PMA), a DAG analog, caused its translocation to cell XtSpred Depletion Inhibits Extension Animal caps isolated from MO-injected embryos were inmembranes. Interestingly, addition of FGF2 also caused PKCδ-G FP to localize to the membrane. This localizacubated with and without activin (10 ng/ml) and assayed for extension. Both uninjected and 4-mis-injected caps tion was inhibited if XtSpry2 was coexpressed with PKCδ-G FP, but not when coexpressed with XtSprd1 remained as rounded balls when left untreated but elongated in the presence of activin ( Figure 6A ). However, ( Figure 4D ). These results provide additional evidence that XtSproutys target a distinct PLCγ-mediated signalanimal caps isolated from Xtsprouty and Xtspred depleted embryos had strikingly different outcomes. Caps ing pathway compared with XtSpreds downstream of the F G FR.
injected with combined Spry1 and Spry2 splice MOs elongated in the absence of activin, but Sprd1 and veloped mesoderm in the absence of activin. Therefore, expression of mesodermal markers was checked in aniSprd2 splice MO caps failed to extend significantly in the presence of activin ( Figure 6A) . In order to conmal caps at mid-gastrula stages by RT-PCR. In the absence of activin, both uninjected and 4-mis-injected firm that we had specifically reduced XtSprouty and XtSpred protein function, we designed another set of embryos expressed a small amount of Xtbra, Xtwnt11, and Xtwnt8 message ( Figure 6D ). This amount is not MOs to these genes, targeting the start ATGs of each mRNA to inhibit translation. Similar to splice MOs, inenough to convert the tissue to mesoderm. Although animal caps depleted for XtSproutys elongated, they jection of Spry2 ATG MOs also induced cap extension in the absence of activin, while Sprd1 ATG MOs inhibhad little increase in the expression of these early mesoderm markers. Therefore, loss of XtSprouty funcited extension with activin ( Figures 6B and 6C ). Therefore, two different MOs targeting separate regions of tion allowed morphogenetic movements to occur without a significant increase in mesoderm specification. the mRNAs caused the same phenotypes, confirming the specificity of the experiments. The resulting animal Conversely, XtSpred depleted animal caps exhibited a significant increase in the expression of these mesocap extensions of MO-injected embryos are summarized in Figure 6C . derm markers in the absence of activin, but did not extend. Therefore, loss of XtSpred function allowed an inExtension of animal caps in the absence of activin was an unexpected and unusual result. We wondered crease in mesoderm specification without induction of morphogenetic movements. Taken together, these rewhether the XtSprouty depleted animal caps also de- sults support the differences observed from mis-expresonly a handful of morphogenic signals. For example, RTK activation by the F G F family of secreted factors sion experiments: XtSproutys inhibit a branch of F G FR signaling that regulates morphogenesis, while the has been implicated in cell differentiation, growth, migration, wound healing, and angiogenesis (Robertson XtSpreds regulate mesoderm specification. Schlessinger, 2000; Sivak and Amaya, 2004) . In some cases F G Fs are used for multiple deciDiscussion sions at essentially the same time (Sivak and Amaya, 2004) . Therefore, an important question arises: how can In recent years, it has become apparent that a great variety of developmental decisions are controlled by the same signal be interpreted as performing different functions, often within the same cells? The related major outcomes of PLCγ activation. Importantly, PKCδ has recently been demonstrated to be an essential Sprouty and Spred families are recently discovered procomponent of the wnt/planar cell polarity pathway inteins that function to directly regulate RTK signaling volved in regulating morphogenesis (Kinoshita et al., downstream of receptor activation (Christofori, 2003; . Ca 2+ signaling has also been implicated in conGuy et al., 2003). Here we have described divergent trol of convergent extension movements without afroles for Sproutys and Spreds in regulation of F G FR fecting cell fate (Wallingford et al., 2001) . Therefore, signaling during vertebrate gastrulation: XtSprouty prothese results provide evidence of a mechanism directly teins inhibit morphogenesis, PKCδ activation, and Ca
2+
linking F G FR signaling to cell migration/cell polarity signaling, and XtSpreds inhibit mesoderm specification pathways. and MAPK activation. In this manner XtSproutys and
In contrast, XtSpreds inhibited mesoderm differentiaXtSpreds can switch between activation of two F G FR tion through strong inhibition of MAPK activation and signal pathways to coordinate distinct developmental had little effect on Ca 2+ signaling or PKCδ activation. events.
Embryos injected with Xtspred1 and Xtspred2 RNAs did not develop mesoderm and displayed an open Functional Divergence of Xtsprouty blastopore phenotype reminiscent of the effect of and Xtspred Proteins dnF G FR (Amaya et al., 1991) . Likewise, XtSpred proGain-and loss-of-function experiments revealed marked teins blocked MAPK activity and extension in animal differences between XtSprouty and XtSpred functions caps. These results are consistent with studies showin vivo. Xtsprouty misexpression resulted in shortened ing that mammalian Spreds inhibit Raf activation upembryos and inhibited morphogenic movements but left stream of MAPK (Kato et al., 2003; Wakioka et al., mesoderm formation intact. FGFR-dependent MAPK ac-2001) . Interestingly, the timing of expression of the tivation was only weakly affected, but PKCδ activation Xtspred genes correlates with the loss of MAPK activity and Ca 2+ signaling were strongly inhibited. Notably, Xbra in embryos, suggesting that the decrease in MAPK acwas induced in untreated animal caps overexpressing tivity is due to the expression of the Xtspred genes. Xtspry2, suggesting that in this context XtSprouty proDepletion of XtSpreds resulted in ventro-posteriorized teins can actually enhance the mesoderm specification embryos that lacked a notochord, similar to the effect pathway. Conversely, XtSprouty depletion caused unof constitutive F G FR signaling (Isaacs et al., 1994) . treated animal caps to undergo morphogenetic extenLoss of XtSpreds in animal caps inhibited elongations sions without an accompanying increase in mesoderm.
with activin treatment. However, increased mesoderm This striking result is similar to the one observed when was detected in untreated Xtspred-depleted caps, indian activated version of protein-tyrosine phosphatase cating excessive mesoderm formation consistent with SHP-2 is missexpressed in animal caps (O'Reilly et al.,
XtSpreds acting as MAPK inhibitors. 2000). Interestingly, this same activated version of SHP-2 Taken together, these results describe a molecular has recently been shown to dephosphorylate and inacbranching of F G FR signaling during mesoderm formativate Sprouty (Hanafusa et al., 2004) . Therefore, it may tion and morphogenesis: a Sprouty-sensitive pathway be possible that untreated animal caps expressing actiaffecting PKCδ activation and Ca 2+ signaling and medivated SHP-2 elongate because Sprouty is inactivated, ating morphogenesis, and a Spred-sensitive pathway a question that is now being investigated.
affecting MAPK activity and mesoderm specification. In other model systems Sproutys have also consisWith the identification of these two regulatory pathways tently been associated with morphogenesis and cell it will now be possible to dissect the various downmigration, processes not normally associated with stream elements involved in each branch. One impor-MAPK signaling (Lim et al., 2000; Yigzaw et al., 2001 , tant aspect to address will be the functional roles con-2003). In particular, depletion of Sproutys has been retributed by the various XtSprouty and XtSpred protein ported to cause excessive morphogenesis in mice and domains in order to identify the elements regulating flies (Hacohen et al., 1998; Tefft et al., 1999 Xtspry1 and 2 are relatively stronger during early gasDevelopmental staging was assessed as described (Nieuwkoop trulation, peaking by stage 10.5, after which expression and Faber, 1967) . Generally, 100 pg of nuclear localized β-galactolevels are reduced. In contrast, Xtsprd1 and 2 are exsidase (pnucβ-gal) or G FP RNA were coinjected as a lineage tracer.
pressed at lower levels during early gastrulation but For animal cap experiments, embryos were injected at animal poles rise after stage 12, when morphogenesis predominates. mesodermal genes such as Xbra. As gastrulation proceeds, Xtsprouty transcription decreases and Xtspred Cellular Localization Assay transcription increases. As a result, the ras/MAPK path-100 pg PKCδ-G FP mRNA was coinjected into X. laevis animal poles with Xtspry2 or Xtsprd1. Animal caps were excised at stage 9 in 1× way is inhibited and the predominant pathway is modified Danilchik's medium (DFA) to prevent healing (Sater et al., switched toward regulation of morphogenesis. A key 1994) and were cultured for 10 min in 1× DFA with or without 100
advantage of this mechanism is that F G F signal interng/ml F G F2 or 1 M PMA (Sigma). Caps were lightly fixed in formalpretation occurs relatively quickly at the cell membrane dehyde for 20 min and G FP localization was determined by confoto allow for plastic and responsive changes to events cal microscopy.
during a rapid early developmental timescale. However, this model may be complicated by positive and/or
Morpholino Design and Microinjections
MOs were purchased from Gene Tools LLC. RNA splice junctions negative feedback due to the fact that Sproutys, and were identified by alignment of cDNA sequences with matching likely Spreds, are themselves downstream targets of genomic sequences. X. tropicalis embryos were injected with 10 FGFR signaling (Minowada et al., 1999; Nutt et al., 2001 ).
ng total MOs before first cleavage, and were generally coinjected
In conclusion, we have uncovered consistent func- of RTK activity.
e1i1, 5#-gtacttacC GTGAC CTC CTC G C C C C-3#; Sprd1 e1i1, 5#-ggtg gcactcacTCTG G CTC CTGTT-3#; Sprd2 e2i2, 5#-ttccttaC CAGTTTG TCATTCAGTC-3#.
Experimental Procedures
Isolation of Xtsprouty and Xtspred Genes RNA Isolation and RT-PCR Total RNA was isolated from embryos and animal caps using the and Construct Design X. tropicalis Sprouty-related homologs were identified through TRIzol reagent according to manufacturer's instructions (Invitrogen). cDNA was synthesized using AMV reverse transcriptase searches of the Wellcome Trust Full Length Database against human and X. laevis EST sequences. Four genes were identified:
(Roche), and PCR reactions were performed using Taq polymerase (Roche) according to established protocol. Primer sequences are Xtsprouty1 (Xtspry1; clone TNeu048o16), Xtsprouty2 (Xtspry2;
